Admission Date:  [**2104-10-24**]              Discharge Date:   [**2104-10-28**]  Date of Birth:  [**2051-3-24**]             Sex:   M  Service: MEDICINE  Allergies: Colchicine / Protein Powder  Attending:[**First Name3 (LF) 477**] Chief Complaint: Hematemesis.
Radiation therapy to esophageal cancer.
History of Present Illness: Mr. [**Known lastname 36365**] is a 53 year-old man with history of stage IV esophageal CA, PUD, ESRD with live donor transplant, PE and DVT on lovenox who presents with hematemesis since this morning.
Note, receiving palliative radiation therapy to T-spine with last dose [**2104-10-21**].
Last dose of Lovenox was 6pm.
NG lavage not performed due to esophageal stent.
He remained HD stable but concern for potential for worsening of hematemesis.
Of note, he had one episode of coffee ground emesis in the ED on last admission in the setting of heparin bolus for PE.
Past Medical History: # Esophageal CA stage IV (metastatic to bones, liver, lung; diagnosed [**4-8**] after esophageal mass discovered; progressive dysphagia s/p palliative esophageal stent [**8-8**]), has been on cisplatin and irinotecan therapy as first line treatment, currently receiving palliative radiation therapy to chest wall and spine, plan for initiating high-dose Taxotere following completion of his palliative radiation therapy # DVT [**8-/2104**] # PE [**9-/2104**] # Remote hx of gastric ulcer not seen on recent EGDs.
# ESRD [**2-2**] to IgA nephropathy s/p kidney transplant [**2091**] and [**2101**] # Status post right arm AVF # Avascular necrosis of the bilateral hips # HTN # Hyperlipidemia # Cataracts status post extraction, # Gout # Squamous cell carcinoma of the face x3 # Status post umbilical hernia repair # Status post ventral hernia repair mass  Social History: Lifetime nonsmoker.
Family History: Mother had a CVA, father had CHF, had a grandfather with gastric cancer.
Extremities: warm, 2+ DP pulses, no edema Neuro: A&Ox3, speech clear and logical, CNII-XII intact, moves all extremities  Pertinent Results: Labs at Admission [**2104-10-24**] 08:20PM   HCT-26.8* [**2104-10-24**] 05:30PM   CK(CPK)-56 [**2104-10-24**] 05:30PM   CK-MB-NotDone cTropnT-0.02* [**2104-10-24**] 12:30PM   HCT-27.4* [**2104-10-24**] 07:25AM   GLUCOSE-85 UREA N-17 CREAT-0.9 SODIUM-137 POTASSIUM-4.1 CHLORIDE-100 TOTAL CO2-29 ANION GAP-12 [**2104-10-24**] 07:25AM   estGFR-Using this [**2104-10-24**] 07:25AM   CK(CPK)-50 [**2104-10-24**] 07:25AM   CALCIUM-9.1 PHOSPHATE-3.7 MAGNESIUM-1.5* [**2104-10-24**] 07:25AM   CK-MB-2 cTropnT-0.02* [**2104-10-24**] 07:25AM   WBC-6.7 RBC-3.41* HGB-10.4* HCT-31.9* MCV-94 MCH-30.5 MCHC-32.6 RDW-16.4* [**2104-10-24**] 07:25AM   NEUTS-80.0* LYMPHS-15.6* MONOS-4.0 EOS-0.3 BASOS-0.1 [**2104-10-24**] 07:25AM   PLT COUNT-300 [**2104-10-24**] 07:25AM   PT-12.6 PTT-35.0 INR(PT)-1.1 .. Studies CT C/A/P ([**2104-10-27**]): IMPRESSION: 1.
Brief Hospital Course: In summary a 53 year-old man with history of stage IV esophageal CA (mets to lungs and spine) s/p esophageal stenting, recent PE and DVT on lovenox, ESRD s/p transplant presents with hematemesis due to bleeding at site of esophageal cancer.
Following the procedure, his hematocrit remained stable and he did not require any transfusions.
He was put on IV proton-pump inhibitor at twice daily dosing.
This therapy was completed without complication.
# Esophageal CA Stage IV with distant metastasis.
At time of admission he was undergoing palliative XRT to his T-spine.
He was continued on long acting morphine with oxycodone for breakthrough pain.
At time of discharge, his pain was well-controlled on regimen of MS Contin and oxycodone.
He will proceed with two more weeks of XRT followed by systemic chemotherapy.
GI was consulted and recommended stopping anticoagulation altogether given his high risk of re-bleeding from the esophageal tumor.
# End-stage Renal Disease He is status post living donor transplant and was followed by the renal transplant service.
He was continued on tacrolimus and Bactrim SS during hospitalization.
DVT prophylaxis was achieved with pneumoboots; he was kept on PPI and bowel prophylaxis throughout hospital course.
Medications on Admission: Emend 125 mg (1)-80 mg (1)-80 mg (1) Capsule, Dose Pack 1 Capsule(s) by mouth once a day Atorvastatin 40 mg once a day Dexamethasone 8 mg PO bid for 3 days beginning a day before chemo ?4mg daily Ativan 0.5 mg by mouth every 6 hours as needed for nausea Lovenox 80mg Q12H MS Contin 30 mg by mouth twice a day Zofran 8 mg Tablet by mouth every 8 hours as needed for nausea Oxycodone 5 mg by mouth every 4 - 6 hours as needed Percocet 5 mg-325 mg 1-2 Tabs PO every 4-6 hours as needed for pain Protonix 40 mg by mouth once a day ?tid Prochlorperazine 10 mg PO every 4-6hours as needed for nausea Ranitidine 300 mg po qhs ?150mg [**Hospital1 **] Sirolimus 4 mg po daily Bactrim SS 1 tab daily Docusate Sodium 100 mg Capsule [**Hospital1 **] prn  Discharge Medications: 1.
Bisacodyl 5 mg Tablet, Delayed Release (E.C.)
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed.
Acetaminophen 325 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 hours) as needed.
Prochlorperazine Maleate 10 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 hours) as needed for nausea.
Trimethoprim-Sulfamethoxazole 80-400 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Tacrolimus 1 mg Capsule Sig: Four (4) Capsule PO Q12H (every 12 hours) as needed for transplant.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Simethicone 80 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO QID (4 times a day) as needed.
Morphine 30 mg Tablet Sustained Release Sig: One (1) Tablet Sustained Release PO Q12H (every 12 hours).
Oxycodone 5 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 hours) as needed.
Omeprazole 40 mg Capsule, Delayed Release(E.C.)
Ranitidine HCl 300 mg Capsule Sig: One (1) Capsule PO at bedtime.
Zofran 8 mg Tablet Sig: One (1) Tablet PO three times a day.
Ativan 0.5 mg Tablet Sig: One (1) Tablet PO q6h prn.
Atorvastatin 40 mg Tablet Sig: One (1) Tablet PO at bedtime.
Emend 125 mg Capsule Sig: One (1) Capsule PO once a day.
SECONDARY DIAGNOSES History of deep venous thrombosis s/p IVC filter placement End stage renal disease s/p kidney transplant   Discharge Condition: Vital signs stable.
Discharge Instructions: You were hospitalized for treatment of bleeding from your esophagus.
You subsequently underwent radiation therapy treatment.
You will continue to have radiation therapy for your esophageal cancer for the next two weeks.
Provider [**Name9 (PRE) **] [**Name8 (MD) 490**], MD, PHD[**MD Number(3) 708**]:[**0-0-**] Date/Time:[**2104-11-11**] 1:30                                [**Name6 (MD) **] [**Name8 (MD) 490**] MD, [**MD Number(3) 491**]  Completed by:[**2104-10-29**
